Position Details
Department of Applied Health Sciences School of Health Sciences College of Medicine and Health
Location: University of Birmingham Edgbaston Birmingham UK
Full time starting salary is normally in the range 36636 to 46049 with potential progression once in post to 48822
Grade: 7
Full Time Fixed Term contract up to April 2027
Closing date: 11th February 2026
Background
We are seeking a highly motivated Postdoctoral Research Fellow to join NIHR-funded research programme evaluating the use of apixaban thromboprophylaxis to prevent venous thromboembolism (VTE) in ambulatory lung cancer patients undergoing systemic anticancer treatment (SACT) Thrombo-STOP trial.
This role will focus on conducting the process evaluation within the wider study exploring how apixaban prophylaxis is delivered in routine care and how it is experienced by patients and clinicians. The insights generated from this work will directly inform the feasibility acceptability and scalability of thromboprophylaxis in lung cancer and help shape future approaches to supportive cancer care.
You will be based within the Department of Applied Health Sciences and work closely with Dr Agnieszka Ignatowicz and wider team collaborating with a multidisciplinary team across academic and clinical settings. This role offers the opportunity to be part of a nationally leading research and clinical collaboration with prospects for career development high-impact publications and the chance in shaping care for people living with lung cancer.
About the project:
Venous thromboembolism (VTE) is common in lung cancer and leads to poorer quality of life increased healthcare costs and higher morbidity and mortality. Risk is particularly high in patients receiving systemic anticancer therapy.
Anticoagulation has been shown to reduce VTE but routine thromboprophylaxis is not current standard care for this population. Subcutaneous low molecular weight heparin can reduce risk but is inconvenient for patients. Apixaban a direct oral anticoagulant (DOAC) is easier to administer has a good safety profile and is widely used in other clinical contexts.
This trial will assess whether six months of apixaban (2.5mg BD) reduces VTE in ambulatory lung cancer patients starting SACT.
Role Summary
Main Duties
The responsibilities may include some but not all of the responsibilities outlined below:
Person Specification
Further particulars can be foundhere
Informal enquiries to Agnieszka Ignatowicz email:
Use of AI in applications:We want to understand your genuine interest in the role and for the written elements of your application to accurately reflect your own communication style. Applications that rely too heavily on AI tools can appear generic and lack the detail we need to assess your skills and experience. Such applications will unlikely be progressed to interview.
We believe there is no such thing as a typical member of University of Birmingham staff and that diversity in its many forms is a strength that underpins the exchange of ideas innovation and debate at the heart of University life. We are committed to proactively addressing the barriers experienced by some groups in our community and are proud to hold Athena SWAN Race Equality Charter and Disability Confident accreditations. We have an Equality Diversity and Inclusion Centre that focuses on continuously improving the University as a fair and inclusive place to work where everyone has the opportunity to succeed. We are also committed to sustainability which is a key part of our strategy. You can find out more about our work to create a fairer university for everyoneon our website.